Combination antibiotic therapy for treatment of Lyme disease
Monica Embers discusses her research findings in this latest course from Invisible International.
Insert HTML here
Monica Embers discusses her research findings in this latest course from Invisible International.
An in-depth review by three leading experts.
Published December 29, 2023 in Healthcare Authored by Jennifer L. Fagen, Jeremy A. Shelton, Jenna Luché-Thayer Abstract: Even though there are approximately half a million new cases of Lyme disease in the US annually, according to the CDC, it is often undiagnosed or misdiagnosed, which can result in a chronic, multisystemic condition. Lyme disease is…
Increased awareness is an important first step in addressing this problem.
In response to an article about Amélie Champagne’s inquiry.
Research continues to reveal an increasingly complex picture of Lyme disease.
Keeping neurological symptoms and Lyme rashes on the radar.
Examining serology and the health burden of Lyme disease and chronic illness with Victoria Sanderson at the G Magnotta Lab.
Encountering Lyme within the Canadian healthcare system.
It’s good to see organizations working towards common research agendas focussed on evidence and patient health.
Using genetic association study methods, we identify an accessory genome signature associated with dissemination in humans and define the individual plasmids and genes that make up this signature.
Canadian family shares the obstacles faced by their adolescent son.
Background Lyme borreliosis (LB), caused by Borrelia burgdorferi (Bb), is the most common tick-borne infection in Germany. Antibodies against Bb are prevalent in the general population but information on temporal changes of prevalence and estimates of seroconversion (seroincidence) and seroreversion are lacking, especially for children and adolescents. Aim We aimed at assessing antibodies against Bb and factors associated with seropositivity…
Associated chronic illnesses: a workshop to examine common, overlapping clinical and biological factors!
Learn the latest about Vector-Borne Diseases from the world’s top experts, October 19-21 in Boston, Massachusetts.